openPR Logo
Press release

Novaliq GmbH Exclusive Interview Released

08-21-2017 10:16 AM CET | Health & Medicine

Press release from: SMi Group

View Full Programme

View Full Programme

Ophthalmic Drugs Interviews Co-Founder, Chief Innovation Officer, Novaliq GmbH

SMi Group’s Ophthalmic Drugs conference is thrilled to welcome Bernhard Guenther, Co-Founder, Chief Innovation Officer, Novaliq GmbH onto the speaker panel for 2017.

Bernhard Guenther is the Co-Founder and Chief Innovation Officer at Novaliq. Before taking over the CIO position at the end of last year, he served for 12 years as the CEO of the company. As the CIO he is responsible for the identification and evaluation of new, early-stage development candidates regarding their potential to become part of Novaliq’s innovative product pipeline.

Hear more from Bernhard at Ophthalmic Drugs 2017 as he presents: ‘Aqueous, preservative-free ocular drug delivery technology with unique properties.’

Gain insight into EyeSol Technology, non-aqueous, preservative-free, poorly soluble drugs and ophthalmic drug delivery. Further details are available at: www.ophthalmicdrugs.com/pr6

For those looking to attend there is currently a £300 early-bird saving!

Further information is available at: www.ophthalmicdrugs.com/opr

SMi Presents the Launch of…
Ophthalmic Drugs
Date: 28th – 29th November 2017
Location: Kensington, London
Website: www.ophthalmicdrugs.com/opr

Sponsored by: Leica Microsystems | Experimentica

---end---

Contact Information:

For all media inquiries contact Pavan Solanki on Tel: +44 (0)20 7827 6048 / Email: psolanki@smi-online.co.uk

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

1 Westminster Bridge Rd, London SE1 7XW

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Novaliq GmbH Exclusive Interview Released here

News-ID: 676392 • Views: 533

More Releases from SMi Group

Darren Green, GSK, conference chair invitation to attend 3rd Annual AI in Drug Discovery Conference
Darren Green, GSK, conference chair invitation to attend 3rd Annual AI in Drug D …
SMi Reports: Conference Chairman Darren Green from GSK personally invites you the 3rd Annual AI in Drug Discovery Conference taking place on 14th and 15th March 2022 in London, UK. The conference will have a focus on case studies from leading pharma and biotech firms, as well as a exploring the latest innovations in machine learning for enhancing discovery pipelines. Darren Green, Director of Computational Chemistry at GSK will be chairing at
Registration is open for SMi’s 5th Annual Pharmaceutical Microbiology East Coast 2022
Registration is open for SMi’s 5th Annual Pharmaceutical Microbiology East Coa …
SMi Group reports: The 5th Annual Pharmaceutical Microbiology East Coast Conference is set to return in April 2022 with a key focus existing methods and novel tools in microbial control to assure continuity in product quality and patient safety. SMi Group is delighted to announce the 5th Annual Pharmaceutical Microbiology East Coast Conference, taking place on the 27th and 28th April 2022 in Boston, USA. The 2022 Conference theme is
SMi’s 10th Annual Pharmaceutical Microbiology UK Conference - A Virtual Conference with Online Access Only
SMi’s 10th Annual Pharmaceutical Microbiology UK Conference - A Virtual Confer …
SMi Reports: SMi Group have made the decision to open the microbiology conference and workshops to all microbiologists by transforming it into a virtual-remote online access event only on 17th and 18th January 2022. SMi’s 10th Annual Pharmaceutical Microbiology UK Conference will no longer take place in London, UK. Instead, the conference is taking place on 17 and 18 January 2022 and will open its doors to a global audience delivering
Co-chairs Philip Hewitt and Stefan Pryzyborski, invitation to join SMi’s 5th Annual 3D Cell Culture Conference
Co-chairs Philip Hewitt and Stefan Pryzyborski, invitation to join SMi’s 5th A …
SMi Group reports: Co-Chairs, Philip Hewitt and Stefan Pryzyborski for SMi’s 5th Annual 3D Cell Culture invite industry professionals to join the conference in February 2022. Philip Hewitt, Global Head of Early Investigative Toxicology, Merck and Stefan Przyborski, Professor in Cell Technology, Durham University invite industry professionals by releasing invite letter to join SMi’s 5th Annual 3D Cell Culture Conference 2022. This event will convene on February 9th – 10th 2022,

All 5 Releases


More Releases for View

Investigation announced for Long-Term Investors in shares of View, Inc. (NASDAQ: …
An investigation was announced over possible breaches of fiduciary duties by certain directors of View, Inc.. Investors who are current long term investors in View, Inc. (NASDAQ: VIEW) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: VIEW stocks follows a lawsuit filed against View, Inc. over alleged securities
Deadline on October 18th coming up for Investors in shares of View, Inc. (NASDAQ …
A deadline is coming up on October 18, 2021 in the lawsuit filed for certain investors of View, Inc. (NASDAQ: VIEW) over alleged securities laws violations by View, Inc. Investors who purchased shares of View, Inc. (NASDAQ: VIEW) have certain options and there are strict and short deadlines running. Deadline: October 18, 2021. NASDAQ: VIEW stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to the
Instant Payments: A Global View
Researchmoz added Most up-to-date research on "Instant Payments: A Global View" to its huge collection of research reports. An insight on the important factors and trends influencing the market. "Instant Payments: A Global View", report contains an in-depth review of instant payment systems around the world, including analysis of the key systems currently in place, and their strengths and weaknesses. Instant payment systems are becoming increasingly prevalent worldwide, as central banks and
Instant Payments: A Global View
ReportsWeb.com published “Instant Payments Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. "Instant Payments: A Global View", report contains an in-depth review of instant payment systems around the world, including analysis of the key systems currently in place, and their strengths and weaknesses. Instant payment systems are becoming
liquidFOLDERS now with timeline view
liquidFOLDERS, an innovative Windows file manager made in Germany, is available for download in a new version 1.2 on the company's website (www.liquidfolders.net/download/). The most prominent addition is a timeline view (picture) that displays all local files chronologically. This is especially useful for browsing pictures. In addition, the new version delivers some minor improvements, and is even more user-friendly than previous releases. "Our team is working on a whole bunch of new
WRS Italia: an international view
Nowadays themes related to the energy saving and recycling are relevant and significant topics to be considered to respect and protect the environment. Government, corporate and enterprises, key players in the countries’ economies, have a pivotal role in the environment safeguard and objectification of these purposes. Thus, these aims can be realized through the development of innovative systems and machines to involve companies to recycle and preserve the environment. Hence, WRS